loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 205022 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Lannett Company, Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 LANNETT CO INC (2)

    filter

    01 TABLET;SUBLINGUAL (2)

    filter

    01 RX (2)

    filter

    01 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (2)

    filter

    01 No (2)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; SUBLINGUAL
    EQ 8MG BASE;EQ 2MG...
    2016-09-19
    205022
    BUPRENORPHINE HYDR...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET; SUBLINGUAL
    EQ 2MG BASE;EQ 0.5...
    2016-09-19
    205022
    BUPRENORPHINE HYDR...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 205022

    Looking for FDA Orange Book APPLICATION 205022 2

    19

    Lannett Company, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE, with a corresponding application number 205022.

    Regulatory Information RX

    With a dosage strength EQ 8MG BASE;EQ 2MG BASE

    Dosage Form Route TABLET; SUBLINGUAL

    Reference Listed Drug No

    Approved since 2016-09-19

    Therapeutic Equivalence (TE) Code AB

    18

    Lannett Company, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE, with a corresponding application number 205022.

    Regulatory Information RX

    With a dosage strength EQ 2MG BASE;EQ 0.5MG BASE

    Dosage Form Route TABLET; SUBLINGUAL

    Reference Listed Drug No

    Approved since 2016-09-19

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY